4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-26-032864
Chief Financial Officer gave up 30,485 shares (to pay taxes)
- Chief Financial Officer acquired 130,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2026-10-15 | Option exercise | +130,000 | 435,673 | D: show line 1 in the form | ||
| Foster Jonathan P. Chief Financial Officer | 2026-10-15 | Shares withheld for taxes | −30,485 | $0.37 | $11,282 | 405,188 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2026-10-15 | Grant or award · Stock Options (right to buy) | +260,000 | 1,287,717 | D: show line 3 in the form | |||||
| Foster Jonathan P. Chief Financial Officer | 2026-10-15 | Grant or award · Restricted Stock Units | +260,000 | 1,547,717 | D: show line 4 in the form | |||||
| Foster Jonathan P. Chief Financial Officer | 2026-10-15 | Option exercise · Restricted Stock Units | −130,000 | 1,417,717 | D: show line 5 in the form |
Loading xslF345X06/rdgdoc.xml…